Inventor · disambiguated record
Margaret D. Moore
Also filed as: MOORE MARGARET · MOORE MARGARET D · MOORE MARGARET DOW
19 granted patents·17 pending applications·164 citations·filing 1998–2019
94Inventor score
Top patents by PatentIndex Score
36 records- 0195US7381794B2Dimeric fusion proteins and materials and methods for producing themZYMOGENETICS INC·Filed 2005·Granted Jun 3, 2008·35 cites·24 claims
- 0293US7537761B2Anti-IL-22RA antibodies and binding partners and methods of using in inflammationZYMOGENETICS INC·Filed 2005·Granted May 26, 2009·18 cites·19 claims
- 0391US7122351B2Dimerized PDGF-D and materials and methods for producing itZYMOGENETICS INC·Filed 2002·Granted Oct 17, 2006·27 cites·26 claims
- 0490US7763445B2Dimeric fusion proteins and materials and methods for producing themZYMOGENETICS INC·Filed 2008·Granted Jul 27, 2010·11 cites·27 claims
- 0588US7393684B2Immunoconjugates of anti-IL-20 antibodies and hybridoma cell lines expressing anti-IL-20 antibodiesZYMOGENETICS INC·Filed 2004·Granted Jul 1, 2008·25 cites·24 claims
- 0687US8822642B2Dimeric fusion proteins and related compositions and methodsLEVIN STEVEN D·Filed 2011·Granted Sep 2, 2014·27 cites·15 claims
- 0786US7655439B2Trimerizing polypeptidesZYMOGENETICS INC·Filed 2006·Granted Feb 2, 2010·6 cites·6 claims
- 0881US8124088B2Methods of treatment using anti-IL-22RA antibodiesXU WENFENG·Filed 2009·Granted Feb 28, 2012·3 cites·4 claims
- 0980US8163286B2Anti-IL-22RA antibodies and binding partners and methods of using in inflammationXU WENFENG·Filed 2009·Granted Apr 24, 2012·2 cites·10 claims
- 1076US9555099B2Vaccines for HSV-2IMMUNE DESIGN CORP·Filed 2013·Granted Jan 31, 2017·2 cites·14 claims
- 1176US7871616B2Anti-IL-22RA antibodies and binding partners and methods of using in inflammationZYMOGENETICS INC·Filed 2009·Granted Jan 18, 2011·1 cites·7 claims
- 1275US10391164B2Vaccines for HSV-2IMMUNE DESIGN CORP·Filed 2016·Granted Aug 27, 2019·1 cites·9 claims
- 1374US7241593B2Materials and methods for preparing dimeric growth factorsZYMOGENETICS INC·Filed 2003·Granted Jul 10, 2007·3 cites·14 claims
- 1473US7262025B2Hybrid vector having a cytomegalovirus enhancer and myeloproliferative sarcoma virus promoterZYMOGENETICS INC·Filed 2003·Granted Aug 28, 2007·2 cites·10 claims
- 1571US9895435B2Vaccines for HSV-2IMMUNE DESIGN CORP·Filed 2013·Granted Feb 20, 2018·1 cites·14 claims
- 1671US2009280562A1Materials and methods for preparing dimeric growth factorsZYMOGENETICS INC·Filed 2009·Application pending·0 cites
- 1767US2009074661A1Anti-il-22ra antibodies and binding partners and methods of using in inflammationZYMOGENETICS INC·Filed 2008·Application pending·0 cites
- 1866US7556941B2Materials and methods for preparing dimeric growth factorsZYMOGENETICS INC·Filed 2006·Granted Jul 7, 2009·0 cites·18 claims
- 1965US2008233115A1Anti-il-20 antibodies and binding partners and methods of using in inflammationZYMOGENETICS INC·Filed 2007·Application pending·0 cites
- 2062US2020023057A1Vaccines for hsv-2IMMUNE DESIGN CORP·Filed 2019·Application pending·0 cites
- 2161US2013315919A1Anti-il-22ra antibodiesZYMOGENETICS INC·Filed 2013·Application pending·0 cites
- 2259US8907068B2Anti-IL-20 antibodies and binding partners and methods of using in inflammationXU WENFENG·Filed 2008·Granted Dec 9, 2014·0 cites·9 claims
- 2359US2012207761A1Anti-il-22ra antibodies and binding partners and methods of using in inflammationXU WENFENG·Filed 2012·Application pending·0 cites
- 2459US2004209330A1Anti-IL-22RA antibodies and binding partners and methods of using in inflammationFiled 2004·Application pending·0 cites
- 2558US8536309B2Methods of producing anti-IL-22RA antibodiesXU WENFENG·Filed 2012·Granted Sep 17, 2013·0 cites·5 claims
- 2658US2010093076A1Soluble il-27 receptorMOORE MARGARET D·Filed 2007·Application pending·0 cites
- 2758US2006134756A1Anti-IL-20 antibodies and binding partners and methods of using in inflammationXU WENFENG·Filed 2004·Application pending·0 cites
- 2857US2008260738A1Single chain fc, methods of making and methods of treatmentMOORE MARGARET D·Filed 2008·Application pending·0 cites
- 2955US2007042464A1Hybrid vector having a cytomegalovirus enhancer and myeloproliferative sarcoma virus promoterZYMOGENETICS INC·Filed 2006·Application pending·0 cites
- 3049US2011263484A1Single chain fc type iii interferons and methods of using sameZYMOGENETICS INC·Filed 2009·Application pending·0 cites
- 3147US8084230B2Trimerizing polypeptidesMOORE MARGARET DOW·Filed 2010·Granted Dec 27, 2011·0 cites·12 claims
- 3247US2011081345A1Single chain fc, methods of making and methods of treatmentMOORE MARGARET D·Filed 2010·Application pending·0 cites
- 3345US2010008917A1Treatment of aplastic anemiaHOSKEN NANCY·Filed 2007·Application pending·0 cites
- 3443US2010092465A1Treatment of graft-versus-host diseaseHOSKEN NANCY·Filed 2007·Application pending·0 cites
- 3537US2014018608A1Empathic Stimulation of the Parasympathetic Nervous SystemMOORE MARGARET·Filed 2012·Application pending·0 cites
- 3629US2002082224A1Non-immunogenic prodrugs and selectable markers for use in gene therapyFiled 1998·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →